Preparation and characterization of gelatin nanoparticles containing pDNA encoding IL-12 and their expression in CT-26 carcinoma cells

Future Oncol. 2013 Aug;9(8):1195-206. doi: 10.2217/fon.13.82.

Abstract

Aim: Gelatin as a biodegradable, nontoxic and biocompatible natural protein is a good candidate for gene delivery. In this study, pDNA-loaded gelatin nanoparticles were prepared and characterized for the expression of the cytokine IL-12 and anti-tumor effects.

Materials & methods: Gelatin-pUMVC3-hIL-12 nanoparticles were prepared by the ethanol precipitation technique and evaluated for physicochemical characteristics, cytotoxiciy and transfection efficiency.

Results: The prepared particles were spherical in shape with sizes varying from 344.27 to 826.23 nm, ζ-potentials between -944 and -165 mV, and greater than 97% encapsulation efficiency. The particles were nontoxic to CT-26 carcinoma cells. The nanoparticles prepared using 0.5% gelatin solution (G14) with a mean particle size of 816.87 nm (polydispersity index = 0.56 ± 0.01) demonstrated maximum transfection efficiency with 2.5-times higher expression compared with the naked plasmid.

Conclusion: Gelatin-DNA nanoparticles using 0.5% gelatin solution had minimal cytotoxicity and can be used as a suitable candidate for further gene delivery studies and applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma* / genetics
  • Carcinoma* / therapy
  • Cell Line, Tumor
  • Colonic Neoplasms* / genetics
  • Colonic Neoplasms* / therapy
  • DNA / administration & dosage
  • DNA / genetics
  • Gelatin / administration & dosage
  • Gelatin / chemistry
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Transfer Techniques
  • Genetic Therapy
  • Humans
  • Interleukin-12 / administration & dosage
  • Interleukin-12 / genetics*
  • Nanoparticles / administration & dosage*

Substances

  • Interleukin-12
  • Gelatin
  • DNA